Perigon Wealth Management, LLC Pfizer Inc Transaction History

Perigon Wealth Management, LLC

$3.67 Billion
Q3 2024

A detailed history of Perigon Wealth Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 127,373 shares of PFE stock, worth $3.28 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

127,373

Previous 119,594 6.5%

Holding current value

$3.28 Million

Previous $3.35 Million 10.16%

% of portfolio

0.1%

Previous 0.1%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$27.7 - $31.39 $215,478 - $244,182	7,779 Added 6.5%	127,373 $3.69 Million
Q2 2024 Aug 02, 2024	SELL	$25.26 - $29.6 $490,145 - $574,358	-19,404 Reduced 13.96%	119,594 $3.35 Million
Q1 2024 Apr 29, 2024	BUY	$25.89 - $29.73 $498,537 - $572,480	19,256 Added 16.08%	138,998 $3.86 Million
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $1.24 Million - $1.61 Million	-47,583 Reduced 28.44%	119,742 $3.45 Million
Q3 2023 Oct 30, 2023	SELL	$32.09 - $37.51 $161,765 - $189,087	-5,041 Reduced 2.92%	167,325 $5.55 Million
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $3.85 Million - $4.45 Million	106,516 Added 161.76%	172,366 $6.32 Million
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $131,483 - $171,172	-3,338 Reduced 4.82%	65,850 $2.69 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $1.08 Million - $1.41 Million	25,899 Added 59.83%	69,188 $3.55 Million
Q3 2022 Dec 13, 2022	SELL	$43.76 - $53.42 $57,150 - $69,766	-1,306 Reduced 2.93%	43,289 $1.89 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $151,734 - $179,909	3,261 Added 7.89%	44,595 $2.34 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $15,280 - $18,934	334 Added 0.81%	41,334 $2.14 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $386,507 - $572,932	9,354 Added 29.56%	41,000 $2.42 Million
Q3 2021 Nov 01, 2021	BUY	$39.25 - $50.42 $963,587 - $1.24 Million	24,550 Added 345.97%	31,646 $1.36 Million
Q3 2021 Oct 25, 2021	SELL	$39.25 - $50.42 $992,397 - $1.27 Million	-25,284 Reduced 78.09%	7,096 $305,000
Q2 2021 Jul 19, 2021	SELL	$35.91 - $40.68 $218,081 - $247,049	-6,073 Reduced 15.79%	32,380 $1.27 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $189,118 - $213,287	-5,647 Reduced 12.8%	38,453 $1.39 Million
Q4 2020 Jan 28, 2021	BUY	$33.47 - $42.56 $312,275 - $397,084	9,330 Added 26.83%	44,100 $1.62 Million
Q3 2020 Nov 03, 2020	BUY	$31.75 - $37.25 $604,583 - $709,314	19,042 Added 121.07%	34,770 $1.28 Million
Q2 2020 Jul 29, 2020	SELL	$30.12 - $36.54 $18,885 - $22,910	-627 Reduced 3.83%	15,728 $514,000
Q1 2020 Apr 17, 2020	BUY	$27.03 - $38.62 $170,991 - $244,310	6,326 Added 63.08%	16,355 $579,000
Q4 2019 Jan 13, 2020	SELL	$32.92 - $37.36 $69,790 - $79,203	-2,120 Reduced 17.45%	10,029 $390,000
Q3 2019 Oct 25, 2019	SELL	$32.49 - $42.13 $57,669 - $74,780	-1,775 Reduced 12.75%	12,149 $443,000
Q2 2019 Aug 05, 2019	SELL	$36.98 - $41.52 $38,792 - $43,554	-1,049 Reduced 7.01%	13,924 $603,000
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $231,704 - $264,168	6,023 Added 67.3%	14,973 $609,000
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $356,178 - $432,022	-10,333 Reduced 53.59%	8,950 $394,000
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $425,969 - $454,126	12,916 Added 202.86%	19,283 $700,000
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $14,550 - $16,881	456 Added 7.71%	6,367 $226,000
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $456,759 - $484,637	-13,733 Reduced 69.91%	5,911 $214,000
Q3 2017 Dec 05, 2017	SELL	$31.0 - $34.15 $1.38 Million - $1.52 Million	-44,437 Reduced 69.35%	19,644 $701,000
Q2 2017 Sep 12, 2017	BUY	N/A	64,081 New	64,081 $2.15 Million
Q3 2011 Nov 14, 2022	SELL	N/A	-1,306	43,289 $1.89 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.

Account

Perigon Wealth Management, LLC Pfizer Inc Transaction History